TACT: Targeted Anti-Cancer Therapies Company Details: 296 Social Audience

TACT: Targeted Anti-Cancer Therapies Overview

Headquarters: Strasbourg, Bas-rhin, Fr
Industry: Research Services
Employees: 1
Founded: 2019
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

cancer therapies chemistry biology mass spectrometry PhD

About TACT: Targeted Anti-Cancer Therapies

The EU-funded TACT project is an innovative, international, multidisciplinary training and research programme designed to train 11 early-stage researchers in the field of anti-cancer therapeutics, creating a new generation of experts. Specifically, the TACT research programme is focused on key principles for the development of a new and more potent generation of protein-drug conjugates employing site-specific bioconjugation methods, environment-specific cleavable linkers, more efficient protein-based targeting systems and new analytical tools for protein characterisation.